Evidence map›Paper›PMID 19705574›Full record

ArticleNeuropharmacology2009

Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.

Gretchen Y López-Hernández, Jeffrey S Thinschmidt, Philippe Morain, Caryn Trocme-Thibierge, William R Kem, Ferenc Soti, Roger L Papke

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Gretchen Y López-HernándezDepartment of Pharmacology and Therapeutics, University of Florida, College of Medicine, Gainesville, FL 32610-0267, USA. gylopez@ufl.edu
Jeffrey S Thinschmidt
Philippe Morain
Caryn Trocme-Thibierge
William R Kem
Ferenc Soti
Roger L Papke
University of Florida · USServier (France) · FRFlorida College · US

Funding

System Gene Delivery for Alzheimer's Disease- SupplementP01AG010485 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI KING, MICHAEL A · 1991 to 2009
$11.3M
Targeting of Alpha7 nAChR for therapeutic effectsR01GM057481 · NIGMS · UNIVERSITY OF FLORIDA · PI PAPKE, ROGER L · 2000 to 2023
$7.6M
TRAINING IN THE NEUROBIOLOGY OF AGINGT32AG000196 · NIA · UNIVERSITY OF FLORIDA · PI SCARPACE, PHILIP J · 1989 to 2011
$2.0M
NIA NIH HHS P01 AG010485NIA NIH HHS P01 AG10485NIA NIH HHS T32 AG000196NIA NIH HHS T32-AG000196NIGMS NIH HHS GM57481-05A2NIGMS NIH HHS R01 GM057481
6 · The paper itself

Abstract

One approach for the identification of therapeutic agents for Alzheimer's disease has focused on the research of alpha7 nAChR-selective agonists such as the partial agonists 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) and, more recently, 2-[2-(4-bromophenyl)-2-oxoethyl]-1-methyl pyridinium (S 24795). An alternative approach for targeting alpha7 nAChR has been the development of positive modulators for this receptor. In this study we examined the interactions between full or partial agonists and positive modulators of alpha7 nAChRs in situ in brain tissue. Three positive modulators were used, 5-hydroxyindole (5-HI), 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxanol-3-yl)-urea (PNU-120596), and genistein. Whole-cell recordings were performed in stratum radiatum interneurons from rat brain slices. Hippocampal interneurons were stimulated by ACh, choline, S 24795, or 4OH-GTS-21, before and after bath perfusion with the positive modulators. 5-HI was not effective at potentiating 200 microM 4OH-GTS-21-evoked responses, however 5-HI induced a sustained potentiation of responses evoked by 30 microM 4OH-GTS-21. When 1 mM ACh and 200 microM 4OH-GTS-21 were applied alternately alpha7-mediated responses to both agonists were reduced, suggesting that high concentration of 4OH-GTS-21 produces residual inhibition or desensitization and that 5-HI is not effective at overcoming receptor desensitization. Similar results were obtained with alpha7 receptors expressed in Xenopus oocytes. Interestingly, responses evoked by S 24795 were potentiated by 5-HI but not by genistein. Additionally, PNU-120596 was able to potentiate alpha7-mediated responses, regardless of the nature of the agonist. We demonstrated that the potentiation of alpha7 nAChR response would depend on the nature and the effective concentration of the agonist involved and its particular interaction with the positive modulator.

Indexed as

Adrenergic alpha-Agonistsalpha7 Nicotinic Acetylcholine ReceptorAnabasineAnimalsCloning, MolecularDNA, ComplementaryEvoked PotentialsHippocampusIndolesInterneuronsIsoxazolesNicotinic AgonistsOocytesPatch-Clamp TechniquesPhenylurea CompoundsPyridinium Compounds1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea3-(4-hydroxy-2-methoxybenzylidene)anabaseine5-hydroxyindoleAdrenergic alpha-Agonistsalpha7 Nicotinic Acetylcholine ReceptorAnabasineChrna7 protein, ratDNA, ComplementaryIndolesIsoxazolesNicotinic AgonistsPhenylurea CompoundsPyridinium CompoundsReceptors, NicotinicS 24795

Identifiers

PMID19705574
PMCPMC2775526
OpenAlexW2125299556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.